Reuters logo
BRIEF-Zogenix completes enrollment in first ZX008 Phase 3 clinical trial in Dravet syndrome
April 27, 2017 / 12:39 PM / 7 months ago

BRIEF-Zogenix completes enrollment in first ZX008 Phase 3 clinical trial in Dravet syndrome

April 27 (Reuters) - Zogenix Inc

* Zogenix completes enrollment in first zx008 phase 3 clinical trial in dravet syndrome

* Zogenix inc- availability of top-line data from the study, expected in q3 of this year zx008 phase 3 for Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below